Pharmaceutical Composition Comprising Empagliflozin And Uses Thereof


The present invention relates to methods for preventing or treating acute or chronic heart failure and for reducing the risk of cardiovascular death, hospitalization for heart failure and other conditions in patients with preserved or reduced ejection fraction by administering empagliflozin to the patient.

Download PDF
Document Preview
Document History
  • Publication: Sep 21, 2017
  • Application: Mar 13, 2017
    WO EP 2017055767 W
  • Priority: Nov 10, 2016
    US US 201662420062 P
  • Priority: Mar 16, 2016
    US US 201662309008 P

Download Citation

Sign in to the Lens